Author:
Giuliani Cesidio,Bucci Ines,Napolitano Giorgio
Reference19 articles.
1. Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole;Giuliani;J Endocrinol,2010
2. Phenyl methimazole inhibits TNF-α-induced VCAM-1 expression in an IFN regulatory factor-1-dependent manner and reduces monocytic cell adhesion to endothelial cells;Dagia;J Immunol,2004
3. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto’s autoimmune thyroiditis;Harii;Mol Endocrinol,2005
4. Phenylmehimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock;Benavides-Peralta;Crit Care Med,2012
5. Kohn LD, Harii N, Benavides-Peralta U, et al. Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression. United States patent 2016 U.S. 9,326,972.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献